Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development (including related party amounts of $228 and $224, respectively)	$ 15,377	$ 9,801
General and administrative (including related party amounts of $134 and $135, respectively)	5,041	4,599
Total operating expenses	20,418	14,400
Loss from operations	(20,418)	(14,400)
Interest income	2,703	3,295
Net loss	$ (17,715)	$ (11,105)
Net loss per share, basic	$ (0.31)	$ (0.2)
Net loss per share, diluted	$ (0.31)	$ (0.2)
Weighted-average shares of common stock outstanding, basic	56,757,827	56,488,527
Weighted-average shares of common stock outstanding, diluted	56,757,827	56,488,527